Results 231 to 240 of about 4,484,193 (288)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

A droplet microfluidics-based platform for generating target-specific, natively-paired immune libraries and identifying potent and developable antibodies. [PDF]

Sci Rep
Ramasubramanian A, Deveney BT, Clark SA, Boutin P, Keepseagle K, Riahi S, Lao T, Salemi M, Kathuria S, Amengual-Rigo P, Dimova D, Marcovici L, Hopke J, Newton J, Mix K, Kramer K, Erasimus H, Furtmann N, Mottet G, Suslov N, Mahendra A, Pemmaraju SR, Chowdhury PS, Weitz DA, Heyman JA.   +24 more
europepmc   +1 more source

Developable surfaces

openaire   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source

Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation. [PDF]

RSC Med Chem
Stevens R, Shrives HJ, Cryan J, Klimaszewska D, Stacey P, Burley GA, Harling JD, Battersby DJ, Miah AH.   +8 more
europepmc   +1 more source

Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
Markers of neutrophil activation are increased in plasma during ALS, and markers of NET formation associate with ALS survival. ABSTRACT Objectives Peripheral neutrophil levels in amyotrophic lateral sclerosis (ALS) inversely correlate with survival, suggesting a role for neutrophils in disease progression.
Lillia A. Baird, Haley McQuown, Jihyun Park, Samuel J. Teener, Ian F. Webber‐Davis, Andrew D. Carter, Dae‐Gyu Jang, Eva L. Feldman, Stephen A. Goutman, Benjamin J. Murdock   +9 more
wiley   +1 more source

A review of full-stack autonomous obstacle avoidance for assistive robots for the disabled. [PDF]

Front Robot AI
Zhang Y, Wang S, Zhao C, Li W, Shi Z, Liu M.   +5 more
europepmc   +1 more source

Applying computational protein design to therapeutic antibody discovery - current state and perspectives. [PDF]

Front Immunol
Bielska W, Jaszczyszyn I, Dudzic P, Janusz B, Chomicz D, Wrobel S, Greiff V, Feehan R, Adolf-Bryfogle J, Krawczyk K.   +9 more
europepmc   +1 more source

Physics-based surface patch analysis for prediction of hydrophobic contribution to viscosity of mAbs. [PDF]

MAbs
Knez B, Ravnik M, Zidar M.
europepmc   +1 more source

Integrated Screening Cascades for Ion-Channel Drug Discovery: Linking Structure, Electrophysiology, Safety Pharmacology, and Human-Relevant Models. [PDF]

Int J Mol Sci
Seo Y.
europepmc   +1 more source